A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])
Recruiting
- Conditions
- Congenital Adrenal Hyperplasia
- Interventions
- Other: Pre-Screening
- First Posted Date
- 2021-11-01
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Adrenas Therapeutics Inc
- Target Recruit Count
- 300
- Registration Number
- NCT05101902
- Locations
- 🇺🇸
Science37, Los Angeles, California, United States
A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)
Phase 1
Recruiting
- Conditions
- Congenital Adrenal Hyperplasia
- Interventions
- Biological: AAV BBP-631
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Adrenas Therapeutics Inc
- Target Recruit Count
- 25
- Registration Number
- NCT04783181
- Locations
- 🇺🇸
Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
🇺🇸National Institutes of Health Clinical Center, Bethesda, Maryland, United States
🇺🇸University of Minnesota, Minneapolis, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath